201 related articles for article (PubMed ID: 17675107)
21. Naringin inhibits the invasion and migration of human glioblastoma cell via downregulation of MMP-2 and MMP-9 expression and inactivation of p38 signaling pathway.
Aroui S; Najlaoui F; Chtourou Y; Meunier AC; Laajimi A; Kenani A; Fetoui H
Tumour Biol; 2016 Mar; 37(3):3831-9. PubMed ID: 26474590
[TBL] [Abstract][Full Text] [Related]
22. Cyclooxygenase-2 and tissue inhibitor of matrix metalloproteinases-1 confer the antimigratory effect of cannabinoids on human trabecular meshwork cells.
Ramer R; Hinz B
Biochem Pharmacol; 2010 Sep; 80(6):846-57. PubMed ID: 20488167
[TBL] [Abstract][Full Text] [Related]
23. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
[TBL] [Abstract][Full Text] [Related]
24. A pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme.
Guzmán M; Duarte MJ; Blázquez C; Ravina J; Rosa MC; Galve-Roperh I; Sánchez C; Velasco G; González-Feria L
Br J Cancer; 2006 Jul; 95(2):197-203. PubMed ID: 16804518
[TBL] [Abstract][Full Text] [Related]
25. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.
Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y
J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952
[TBL] [Abstract][Full Text] [Related]
26. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
[TBL] [Abstract][Full Text] [Related]
27. The CB2 cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathway.
Herrera B; Carracedo A; Diez-Zaera M; Gómez del Pulgar T; Guzmán M; Velasco G
Exp Cell Res; 2006 Jul; 312(11):2121-31. PubMed ID: 16624285
[TBL] [Abstract][Full Text] [Related]
28. Cannabinoids as potential new therapy for the treatment of gliomas.
Parolaro D; Massi P
Expert Rev Neurother; 2008 Jan; 8(1):37-49. PubMed ID: 18088200
[TBL] [Abstract][Full Text] [Related]
29. Fatty acid amide hydrolase inhibitors confer anti-invasive and antimetastatic effects on lung cancer cells.
Winkler K; Ramer R; Dithmer S; Ivanov I; Merkord J; Hinz B
Oncotarget; 2016 Mar; 7(12):15047-64. PubMed ID: 26930716
[TBL] [Abstract][Full Text] [Related]
30. The pseudokinase tribbles homologue-3 plays a crucial role in cannabinoid anticancer action.
Salazar M; Lorente M; García-Taboada E; Hernández-Tiedra S; Davila D; Francis SE; Guzmán M; Kiss-Toth E; Velasco G
Biochim Biophys Acta; 2013 Oct; 1831(10):1573-8. PubMed ID: 23567453
[TBL] [Abstract][Full Text] [Related]
31. Ceramide sensitizes astrocytes to oxidative stress: protective role of cannabinoids.
Carracedo A; Geelen MJ; Diez M; Hanada K; Guzmán M; Velasco G
Biochem J; 2004 Jun; 380(Pt 2):435-40. PubMed ID: 14979873
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
Rosenberg EC; Patra PH; Whalley BJ
Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
[TBL] [Abstract][Full Text] [Related]
33. The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids.
McAllister SD; Soroceanu L; Desprez PY
J Neuroimmune Pharmacol; 2015 Jun; 10(2):255-67. PubMed ID: 25916739
[TBL] [Abstract][Full Text] [Related]
34. R(+)-methanandamide and other cannabinoids induce the expression of cyclooxygenase-2 and matrix metalloproteinases in human nonpigmented ciliary epithelial cells.
Rösch S; Ramer R; Brune K; Hinz B
J Pharmacol Exp Ther; 2006 Mar; 316(3):1219-28. PubMed ID: 16330497
[TBL] [Abstract][Full Text] [Related]
35. Transforming growth factor-beta1 induces tissue inhibitor of metalloproteinase-1 expression via activation of extracellular signal-regulated kinase and Sp1 in human fibrosarcoma cells.
Kwak HJ; Park MJ; Cho H; Park CM; Moon SI; Lee HC; Park IC; Kim MS; Rhee CH; Hong SI
Mol Cancer Res; 2006 Mar; 4(3):209-20. PubMed ID: 16547158
[TBL] [Abstract][Full Text] [Related]
36. Tissue inhibitor of metalloproteinase-3 expression from an oncolytic adenovirus inhibits matrix metalloproteinase activity in vivo without affecting antitumor efficacy in malignant glioma.
Lamfers ML; Gianni D; Tung CH; Idema S; Schagen FH; Carette JE; Quax PH; Van Beusechem VW; Vandertop WP; Dirven CM; Chiocca EA; Gerritsen WR
Cancer Res; 2005 Oct; 65(20):9398-405. PubMed ID: 16230403
[TBL] [Abstract][Full Text] [Related]
37. Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1.
Ramer R; Bublitz K; Freimuth N; Merkord J; Rohde H; Haustein M; Borchert P; Schmuhl E; Linnebacher M; Hinz B
FASEB J; 2012 Apr; 26(4):1535-48. PubMed ID: 22198381
[TBL] [Abstract][Full Text] [Related]
38. [Cannabis and cannabinoids as drugs].
Khiabani HZ; Mørland J
Tidsskr Nor Laegeforen; 2007 Mar; 127(5):579-82. PubMed ID: 17332810
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic potential of cannabinoids in CNS disease.
Croxford JL
CNS Drugs; 2003; 17(3):179-202. PubMed ID: 12617697
[TBL] [Abstract][Full Text] [Related]
40. The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells.
Carracedo A; Lorente M; Egia A; Blázquez C; García S; Giroux V; Malicet C; Villuendas R; Gironella M; González-Feria L; Piris MA; Iovanna JL; Guzmán M; Velasco G
Cancer Cell; 2006 Apr; 9(4):301-12. PubMed ID: 16616335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
